07:00 , May 13, 2013 |  BC Week In Review  |  Company News

Batavia Bioservices, University of Amsterdam deal

The university's UvA Holding B.V. commercial arm granted Batavia exclusive rights to market and develop plasmid-based STEP technology to develop recombinant protein-producing mammalian cell lines. The technology was developed at CellaGenics B.V., which UvA spun...